Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEurop
<p>Abstract</p> <p>Background</p> <p><it>Plasmodium vivax </it>is the second most common species among malaria patients diagnosed in Europe, but epidemiological and clinical data on imported <it>P. vivax </it>malaria are limited. The TropNetEurop...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2004-03-01
|
| Series: | Malaria Journal |
| Online Access: | http://www.malariajournal.com/content/3/1/5 |
| _version_ | 1818060879570141184 |
|---|---|
| author | Malvy DJM Kotlowski A Iversen J Knobloch J Kapaun A Kollaritsch H Hatz C Holthoff-Stich ML Laferl H Myrvang B Schmid ML Puente S Hellgren U Bisoffi Z Lopez-Velez R Matteelli A McWhinney P Björkman A Clerinx J Behrens RH Gjørup I Beran J Schunk M Zoller T Probst M Gascon J Jelinek T Mühlberger N Kern P Fry G Siikamaki H Schulze MH Soula G Paul M Prat J Gómez i Lehmann V Bouchaud O Cunha S da Atouguia J Boecken G |
| author_facet | Malvy DJM Kotlowski A Iversen J Knobloch J Kapaun A Kollaritsch H Hatz C Holthoff-Stich ML Laferl H Myrvang B Schmid ML Puente S Hellgren U Bisoffi Z Lopez-Velez R Matteelli A McWhinney P Björkman A Clerinx J Behrens RH Gjørup I Beran J Schunk M Zoller T Probst M Gascon J Jelinek T Mühlberger N Kern P Fry G Siikamaki H Schulze MH Soula G Paul M Prat J Gómez i Lehmann V Bouchaud O Cunha S da Atouguia J Boecken G |
| author_sort | Malvy DJM |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p><it>Plasmodium vivax </it>is the second most common species among malaria patients diagnosed in Europe, but epidemiological and clinical data on imported <it>P. vivax </it>malaria are limited. The TropNetEurop surveillance network has monitored the importation of vivax malaria into Europe since 1999.</p> <p>Objectives</p> <p>To present epidemiological and clinical data on imported <it>P. vivax </it>malaria collected at European level.</p> <p>Material and methods</p> <p>Data of primary cases of <it>P. vivax </it>malaria reported between January 1999 and September 2003 were analysed, focusing on disease frequency, patient characteristics, place of infection, course of disease, treatment and differences between network-member countries.</p> <p>Results</p> <p>Within the surveillance period 4,801 cases of imported malaria were reported. 618 (12.9%) were attributed to <it>P. vivax</it>. European travellers and immigrants were the largest patient groups, but their proportion varied among the reporting countries. The main regions of infection in descending order were the Indian subcontinent, Indonesia, South America and Western and Eastern Africa, as a group accounting for more than 60% of the cases. Regular use of malaria chemoprophylaxis was reported by 118 patients. With 86 (inter-quartile range 41–158) versus 31 days (inter-quartile range 4–133) the median symptom onset was significantly delayed in patients with chemoprophylaxis (p < 0.0001). Common complaints were fever, headache, fatigue, and musculo-skeletal symptoms. All patients survived and severe clinical complications were rare. Hospitalization was provided for 60% and primaquine treatment administered to 83.8% of the patients, but frequencies varied strongly among reporting countries.</p> <p>Conclusions</p> <p>TropNetEurop data can contribute to the harmonization of European treatment policies.</p> |
| first_indexed | 2024-12-10T13:39:26Z |
| format | Article |
| id | doaj.art-e6f44cc2c36c4203a553d6c986a05b86 |
| institution | Directory Open Access Journal |
| issn | 1475-2875 |
| language | English |
| last_indexed | 2024-12-10T13:39:26Z |
| publishDate | 2004-03-01 |
| publisher | BMC |
| record_format | Article |
| series | Malaria Journal |
| spelling | doaj.art-e6f44cc2c36c4203a553d6c986a05b862022-12-22T01:46:44ZengBMCMalaria Journal1475-28752004-03-0131510.1186/1475-2875-3-5Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEuropMalvy DJMKotlowski AIversen JKnobloch JKapaun AKollaritsch HHatz CHolthoff-Stich MLLaferl HMyrvang BSchmid MLPuente SHellgren UBisoffi ZLopez-Velez RMatteelli AMcWhinney PBjörkman AClerinx JBehrens RHGjørup IBeran JSchunk MZoller TProbst MGascon JJelinek TMühlberger NKern PFry GSiikamaki HSchulze MHSoula GPaul MPrat J Gómez iLehmann VBouchaud OCunha S daAtouguia JBoecken G<p>Abstract</p> <p>Background</p> <p><it>Plasmodium vivax </it>is the second most common species among malaria patients diagnosed in Europe, but epidemiological and clinical data on imported <it>P. vivax </it>malaria are limited. The TropNetEurop surveillance network has monitored the importation of vivax malaria into Europe since 1999.</p> <p>Objectives</p> <p>To present epidemiological and clinical data on imported <it>P. vivax </it>malaria collected at European level.</p> <p>Material and methods</p> <p>Data of primary cases of <it>P. vivax </it>malaria reported between January 1999 and September 2003 were analysed, focusing on disease frequency, patient characteristics, place of infection, course of disease, treatment and differences between network-member countries.</p> <p>Results</p> <p>Within the surveillance period 4,801 cases of imported malaria were reported. 618 (12.9%) were attributed to <it>P. vivax</it>. European travellers and immigrants were the largest patient groups, but their proportion varied among the reporting countries. The main regions of infection in descending order were the Indian subcontinent, Indonesia, South America and Western and Eastern Africa, as a group accounting for more than 60% of the cases. Regular use of malaria chemoprophylaxis was reported by 118 patients. With 86 (inter-quartile range 41–158) versus 31 days (inter-quartile range 4–133) the median symptom onset was significantly delayed in patients with chemoprophylaxis (p < 0.0001). Common complaints were fever, headache, fatigue, and musculo-skeletal symptoms. All patients survived and severe clinical complications were rare. Hospitalization was provided for 60% and primaquine treatment administered to 83.8% of the patients, but frequencies varied strongly among reporting countries.</p> <p>Conclusions</p> <p>TropNetEurop data can contribute to the harmonization of European treatment policies.</p>http://www.malariajournal.com/content/3/1/5 |
| spellingShingle | Malvy DJM Kotlowski A Iversen J Knobloch J Kapaun A Kollaritsch H Hatz C Holthoff-Stich ML Laferl H Myrvang B Schmid ML Puente S Hellgren U Bisoffi Z Lopez-Velez R Matteelli A McWhinney P Björkman A Clerinx J Behrens RH Gjørup I Beran J Schunk M Zoller T Probst M Gascon J Jelinek T Mühlberger N Kern P Fry G Siikamaki H Schulze MH Soula G Paul M Prat J Gómez i Lehmann V Bouchaud O Cunha S da Atouguia J Boecken G Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEurop Malaria Journal |
| title | Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEurop |
| title_full | Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEurop |
| title_fullStr | Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEurop |
| title_full_unstemmed | Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEurop |
| title_short | Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEurop |
| title_sort | epidemiology and clinical features of vivax malaria imported to europe sentinel surveillance data from tropneteurop |
| url | http://www.malariajournal.com/content/3/1/5 |
| work_keys_str_mv | AT malvydjm epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT kotlowskia epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT iversenj epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT knoblochj epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT kapauna epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT kollaritschh epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT hatzc epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT holthoffstichml epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT laferlh epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT myrvangb epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT schmidml epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT puentes epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT hellgrenu epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT bisoffiz epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT lopezvelezr epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT matteellia epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT mcwhinneyp epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT bjorkmana epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT clerinxj epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT behrensrh epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT gjørupi epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT beranj epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT schunkm epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT zollert epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT probstm epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT gasconj epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT jelinekt epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT muhlbergern epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT kernp epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT fryg epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT siikamakih epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT schulzemh epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT soulag epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT paulm epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT pratjgomezi epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT lehmannv epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT bouchaudo epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT cunhasda epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT atouguiaj epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop AT boeckeng epidemiologyandclinicalfeaturesofvivaxmalariaimportedtoeuropesentinelsurveillancedatafromtropneteurop |